Acute Low Back Pain Clinical Trial
Official title:
Clinical Pathways and Patients' Attitudes in Acute Low Back Pain
In France the prevalence of low back pain is 70 to 80 %. It's the leading cause of health
expenditure in Europe and costs 900 million euros per year to health insurance in France.
This is the second reason to consult a general practitioner. Acute low back pain is defined
as low back pain lasts less than 6 weeks. It represents 60 to 70 % of low back pain but only
20% of the costs induced by low back pain in general. In fact, acute low back pain often
heals spontaneously.
Risk factors for acute low back pain and risk factors for chronic low back pain have been the
subject of many publications. They remain very difficult to prevent in practice because of
their multiplicity. Preventing acute low back pain is part of the prevention of chronic low
back pain. Patient care management of low back pain is well codified and consensual in the
various international recommendations. However, their application is sometimes very disparate
and bad habits on both patients and professionals persist. Advices recommended in the case of
low back pain are widely disseminated but their applications are little studied. In 2017, in
France, health insurance started a "back pain" prevention campaign with the objective of
raising awareness of good attitudes in the event of back pain. It made an initial assessment
of the different knowledges concerning spinal pain in the general population but also in the
medical population with the aim of improving them. It appears that number of patients would
not consult physician in this case. The many proposals of care and the diversity of medical
professionals, paramedics and other stakeholders, proposing to cure low back pain form as
many different clinical pathways. Use of alternative or unconventional medicines is poorly
assessed. In this context, it seems relevant to evaluate patient clinical pathways and
patients' attitudes.
The aim of the study is to explore patient clinical pathways and patients' attitudes in acute low back pain ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00343057 -
DISCO - Influence of a Simple Information Booklet on the Evolution of Acute Low Back Pain (LBP)
|
N/A | |
| Completed |
NCT00010985 -
Usual Care Vs Choice of Alternative Rx: Low Back Pain
|
Phase 3 | |
| Completed |
NCT00000418 -
Psychosocial Treatment for Acute Low Back Pain
|
Phase 2 | |
| Completed |
NCT06022484 -
Magnetic Resonance Imaging and Acute Low Back Pain
|
||
| Completed |
NCT01708915 -
Nonivamide/Nicoboxil Ointment in Acute Low Back Pain
|
Phase 3 | |
| Completed |
NCT00782925 -
An Educational and Exercise Program as Secondary Prevention of Recurrent Lower Back Pain in Healthcare Workers
|
N/A | |
| Completed |
NCT04968158 -
Efficacy and Safety of Fixed-dose Combination of Etoricoxib/Tramadol vs Acetaminophen/Tramadol for Acute Low Back Pain
|
Phase 3 | |
| Completed |
NCT05001555 -
Efficacy and Safety of Dexketoprofen/Vitamin B vs Dexketoprofen for Post-traumatic Cervical Sprain Grade I-II
|
Phase 3 | |
| Completed |
NCT03424707 -
A Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of DW340 in Patients With Acute Low Back Pain
|
Phase 2 | |
| Recruiting |
NCT04328428 -
The Evaluation of Single Acupoint Therapy to Acute Low Back Pain
|
N/A | |
| Completed |
NCT00643383 -
A Two-Arm Study Comparing the Analgesic Efficacy and Safety of Acetaminophen and Tramadol Combination BID Versus Placebo for the Treatment of Acute Low Back Pain
|
Phase 3 | |
| Completed |
NCT02517762 -
Acute Low Back Pain: Causes, Mechanisms, Treatment and Followup
|
N/A | |
| Completed |
NCT04772781 -
Efficacy and Safety of S (+) - Ibuprofen in the Treatment of Mechanical Low Back Pain
|
Phase 2 | |
| Completed |
NCT00706043 -
French Validation Orebro Musculoskeletal Pain Screening Questionnaire (OMPSQ) Questionnaire
|
||
| Completed |
NCT00525811 -
Development of a Web-Based Interactive Patient Decision Aid for the Treatment of Acute Low Back Pain and Depression
|
N/A | |
| Completed |
NCT03341832 -
Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain
|
Phase 2 | |
| Completed |
NCT00952068 -
A Pharmacodynamic/Pharmacokinetic Study to Determine the Onset of Analgesic Effect and Plasma Levels of Tramadol in Patients With Acute Low Back Pain Receiving a Single 200 mg Dose of Tramadol Contramid® Once-a-Day
|
Phase 2 | |
| Completed |
NCT04082975 -
Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back Pain
|
Phase 3 | |
| Recruiting |
NCT02037763 -
A Prospective Trial to Identify Biomarkers Involved in the Transition From Acute to Persistent Chronic Low Back Pain
|
N/A | |
| Completed |
NCT01638286 -
Study to Evaluate a Pharmacokinetic Drug Interaction Between Eperisone Hydrochloride and Aceclofenac in Healthy Male Subjects
|
N/A |